phase readout
saveNCT07524374: SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy
NOT_YET_RECRUITINGupdated 40m ago
community read0 votes
Sponsor: Zhigang Li. Phase: PHASE2. Conditions: ESCC
view source ↗
comments(0)
5-min edit window · permanent after that